(Q48332119)

10 February 2018

title

Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease (English)

1 reference

10 February 2018

0 references

5

1 reference

10 February 2018

Nicholas Mitsios

10

1 reference

10 February 2018

Stefan Schulz

19

1 reference

10 February 2018

Annica Rönnbäck

Annica Rönnbäck

14

0 references

Jan Mulder

Jan Mulder

6

0 references

Mathias Uhlén

11

Mathias Uhlén

1 reference

10 February 2018

20

Tomas Hökfelt

1 reference

10 February 2018

Tibor Harkány

17

Tibor Harkany

1 reference

10 February 2018

Jens F. Rehfeld

16

Jens F Rehfeld

1 reference

10 February 2018

author name string

Csaba Ádori

1

1 reference

10 February 2018

Laura Glück

2

1 reference

10 February 2018

Swapnali Barde

3

1 reference

10 February 2018

Takashi Yoshitake

4

1 reference

10 February 2018

Zsófia Maglóczky

7

1 reference

10 February 2018

László Havas

8

1 reference

10 February 2018

Kata Bölcskei

9

1 reference

10 February 2018

János Szolcsányi

12

1 reference

10 February 2018

Thue Schwartz

15

1 reference

10 February 2018

Miklós Palkovits

18

1 reference

10 February 2018

publication date

13 February 2015

1 reference

10 February 2018

published in

Acta Neuropathologica

1 reference

10 February 2018

volume

129

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

541-563

1 reference

10 February 2018

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Morphologic alterations of chohnergic processes in the neocortex of aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

The relationship between subcortical tau pathology and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Alzheimer's pathogenesis: is there neuron-to-neuron propagation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Noradrenergic mechanisms in stress and anxiety: II. Clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Neuropeptides from concept to online database www.neuropeptides.nl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Silver methenamine stain for electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Pharmacological strategies for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin in the central nervous system: physiology and pathological modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin, Alzheimer's disease and cognition: an old story coming of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Trophic-factor modulation of cortical acetylcholinesterase reappearance following transection of the medial cholinergic pathway in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin enhances nerve growth factor-induced neurite outgrowth in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Light-microscopic localization of somatostatin binding sites in the locus coeruleus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Disease-specific patterns of locus coeruleus cell loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Stress, PTSD, and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Locus ceruleus degeneration is ubiquitous in Alzheimer's disease: possible implications for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Classification and nomenclature of somatostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Ear2 deletion causes early memory and learning deficits in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Role of brain norepinephrine in the behavioral response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Neuropathological diagnostic criteria for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Vulnerability to aging in the rat serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Transmitter histochemistry of the sympathetic adrenergic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Comparative investigations on the actions of ACTH1-24, somatostatin, neurotensin, substance P and vasopressin on locus coeruleus neuronal activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin in catecholamine-rich nuclei of the brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Biochemical and immunological analyses of cytoskeletal domains of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

A noradrenergic theory of cognitive reserve: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Neuropeptide tyrosine in the rat adrenal gland--immunohistochemical and in situ hybridization studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Functional neuroanatomy of the central noradrenergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Intracerebroventricular and locus coeruleus microinjections of somatostatin antagonist decrease REM sleep in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Aging of the serotonergic system in the rat forebrain: an immunocytochemical and neurochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Somatostatinergic systems in brain: networks and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Degeneration of monoaminergic fibers in the aged micrencephalic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Functional consequences of locus coeruleus degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1394-3

10.1007/S00401-015-1394-3

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018